Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7125 |
filingDate |
2001-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2004-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2004530629-A |
titleOfInvention |
Immunostimulatory RNA / DNA hybrid molecule |
abstract |
The present invention relates to immunological compositions related to immunostimulatory intrastrand DNA / RNA hybrid oligonucleotides (HDRs) that optimally encode one or more CpG motifs, which may be unmethylated CpG motifs. Provide a method. Administration of these compounds, alone or in association with one or more target antigens, promotes innate and antigen-specific immunity. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008523094-A |
priorityDate |
2000-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |